Developing a risk mitigation plan for gene therapy manufacturing

John Moscariello

Senior Director, Viral Vector & Gene Editing Process Development, Bristol-Myers Squib 

Claire Davies

Head of Bioanalytics, Sanofi

Michael Brewer

Director, Global Principal Consultant, Regulatory, BioProduction, Thermo Fisher Scientific

Christine Le Bec

Head of CMC Gene Therapy, Sensorion Pharma 

Please enter your email to access content Read now